Skip to main content

Idexx Laboratories income statement

  • IDXX · Nasdaq
  • Biotechnology
  • Health Care Equipment
  • S&P 500
$704.23+0.89%Close 13 Nov 2026 · Market value $55.66B

Idexx Laboratories reported revenue of $4.30 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 10.4% from fiscal 2024. Net income was $1.06 billion and diluted earnings per share $13.08.

From Idexx Laboratories's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Idexx Laboratories income statement, annual
USDFY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$1.02B$1.03B$1.10B$1.22B$1.29B$1.38B$1.49B$1.60B$1.78B$1.97B$2.21B$2.41B$2.71B$3.22B$3.37B$3.66B$3.90B$4.30B$4.66B
Revenue growth—+0.7%+7.0%+10.4%+6.1%+6.5%+7.9%+7.8%+10.8%+10.9%+12.4%+8.8%+12.5%+18.8%+4.7%+8.7%+6.5%+10.4%—
Net interest income—$1.43M−$1.75M−$1.80M−$1.95M−$3.50M−$13.70M−$26.77M−$28.39M−$31.97M−$33.59M−$30.63M−$32.54M−$29.37M−$38.79M−$35.95M———
Cost of revenue$494.3M$505.4M$524.8M$572.2M$594.2M$620.9M$669.7M$711.6M$800.0M$871.7M$971.7M$1.04B$1.14B$1.33B$1.36B$1.47B$1.52B$1.64B$1.74B
Gross profit$529.8M$526.3M$578.6M$646.5M$699.1M$756.1M$816.1M$890.3M$975.4M$1.10B$1.24B$1.37B$1.57B$1.89B$2.00B$2.19B$2.38B$2.66B$2.92B
Gross margin51.7%51.0%52.4%53.0%54.1%54.9%54.9%55.6%54.9%55.7%56.1%56.7%58.0%58.8%59.5%59.8%61.0%61.8%62.7%
Research and development$70.67M$65.12M$68.60M$76.04M$82.01M$88.00M$98.26M$99.68M$101.1M$109.2M$117.9M$133.2M$141.2M$161.0M$254.8M$191.0M$219.8M$251.2M$266.9M
Selling, general and administrative$286.6M$285.2M$306.1M$334.2M$354.6M$401.4M$457.6M$482.5M$524.1M$575.2M$632.3M$679.5M$735.3M$796.4M$850.8M$901.9M$1.03B$1.05B$1.15B
Operating expenses$357.3M$350.3M$374.7M$410.3M$436.6M$489.4M$555.9M$590.4M$625.2M$684.4M$750.2M$812.7M$876.5M$957.4M$1.11B$1.09B$1.25B$1.30B$1.42B
Operating income$172.5M$176.0M$203.9M$236.2M$262.6M$266.8M$260.3M$299.9M$350.2M$413.0M$491.3M$552.8M$694.5M$932.0M$898.8M$1.10B$1.13B$1.36B$1.51B
Operating margin16.8%17.1%18.5%19.4%20.3%19.4%17.5%18.7%19.7%21.0%22.2%23.0%25.7%29.0%26.7%30.0%29.0%31.6%32.3%
Interest expense$4.59M$1.92M$2.42M$3.55M$3.85M$5.39M$15.43M$29.24M$32.05M$37.23M$34.74M$31.05M$33.13M$29.81M$39.86M$41.58M$31.20M$38.85M$34.59M
Income before tax$170.2M$174.5M$202.1M$234.4M$260.6M$263.3M$246.6M$273.1M$321.8M$381.1M$457.7M$522.2M$662.0M$902.7M$860.0M$1.06B$1.11B$1.32B$1.48B
Income tax expense$54.02M$52.30M$60.81M$72.67M$82.33M$75.47M$64.60M$81.01M$99.79M$117.8M$80.69M$94.43M$79.85M$157.8M$180.9M$216.1M$222.0M$264.7M$296.8M
Effective tax rate31.7%30.0%30.1%31.0%31.6%28.7%26.2%29.7%31.0%30.9%17.6%18.1%12.1%17.5%21.0%20.4%20.0%20.0%20.1%
Net income$116.2M$122.2M$141.3M$161.8M$178.3M$187.8M$181.9M$192.1M$222.0M$263.1M$377.0M$427.7M$581.8M$744.8M$679.1M$845.0M$887.9M$1.06B$1.18B
Net margin11.3%11.8%12.8%13.3%13.8%13.6%12.2%12.0%12.5%13.4%17.0%17.8%21.5%23.2%20.2%23.1%22.8%24.6%25.4%
EPS · diluted$0.93$1.01$1.19$1.39$1.59$1.74$1.79$2.05$2.44$2.94$4.26$4.89$6.71$8.60$8.03$10.06$10.67$13.08$14.82
Diluted weighted average shares124M121M119M116M112M108M102M93.6M90.9M89.6M88.5M87.5M86.7M86.6M84.6M84.0M83.2M81.0M79.8M
Basic weighted average shares120M118M115M114M110M106M100M92.6M89.7M87.8M86.9M86.1M85.3M85.2M83.6M83.1M82.5M80.4M79.3M
EBITDA$220.4M$225.7M$249.8M$284.4M$315.0M$321.4M$319.1M$368.9M$428.5M$496.2M$574.5M$640.9M$790.5M$1.04B$1.01B$1.21B$1.26B$1.51B$1.66B
EBITDA margin21.5%21.9%22.6%23.3%24.4%23.3%21.5%23.0%24.1%25.2%26.0%26.6%29.2%32.2%30.0%33.1%32.3%35.0%35.7%
Depreciation & amortization$47.98M$49.77M$45.96M$48.20M$52.41M$54.60M$58.89M$68.96M$78.22M$83.14M$83.18M$88.01M$96.00M$104.6M$111.9M$114.9M$129.9M$145.2M$158.0M
Stock-based compensation$10.50M$11.62M$13.26M$15.50M$15.95M$16.54M$18.10M$19.88M$19.89M$23.52M$25.16M$39.28M$30.95M$37.76M$49.77M$59.74M$60.30M$60.01M$64.75M

Quarterly

Idexx Laboratories income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$901.6M$964.1M$1.00B$975.5M$954.3M$998.4M$1.11B$1.11B$1.09B$1.14B$1.22B$1.21B
Net interest income−$5.63M−$3.48M−$4.75M−$4.98M————————
Cost of revenue$375.4M$371.0M$384.4M$379.5M$383.6M$375.0M$414.7M$421.9M$432.5M$418.1M$437.5M$449.9M
Gross profit$526.2M$593.1M$619.2M$596.0M$570.7M$623.4M$694.7M$683.4M$658.1M$722.7M$779.1M$764.3M
Gross margin58.4%61.5%61.7%61.1%59.8%62.4%62.6%61.8%60.3%63.4%64.0%62.9%
Research and development$51.81M$52.63M$55.45M$53.98M$57.73M$59.06M$61.90M$63.41M$66.83M$65.79M$65.43M$68.82M
Selling, general and administrative$229.1M$241.5M$299.9M$238.2M$251.2M$247.8M$259.8M$265.1M$275.7M$294.4M$288.1M$293.1M
Operating expenses$280.9M$294.1M$355.4M$292.1M$309.0M$306.8M$321.7M$328.5M$342.5M$360.2M$353.5M$361.9M
Operating income$245.3M$299.0M$263.8M$303.9M$261.7M$316.5M$373.0M$354.8M$315.6M$362.6M$425.6M$402.3M
Operating margin27.2%31.0%26.3%31.2%27.4%31.7%33.6%32.1%28.9%31.8%35.0%33.1%
Interest expense$9.27M$7.91M$8.10M$7.70M$7.50M$7.67M$11.32M$10.65M$9.21M$7.74M$10.18M$7.46M
Income before tax$239.7M$295.5M$259.1M$298.9M$256.4M$310.1M$362.4M$344.8M$307.0M$355.4M$417.2M$399.3M
Income tax expense$45.15M$59.90M$55.76M$66.07M$40.24M$67.41M$68.36M$70.16M$58.79M$77.00M$78.81M$82.18M
Effective tax rate18.8%20.3%21.5%22.1%15.7%21.7%18.9%20.4%19.2%21.7%18.9%20.6%
Net income$194.5M$235.6M$203.3M$232.8M$216.1M$242.7M$294.0M$274.6M$248.2M$278.4M$338.4M$317.1M
Net margin21.6%24.4%20.3%23.9%22.7%24.3%26.5%24.8%22.8%24.4%27.8%26.1%
EPS · diluted$2.32$2.81$2.44$2.80$2.62$2.96$3.63$3.40$3.08$3.47$4.27$4.01
Diluted weighted average shares83.9M84.0M83.4M83.1M82.6M81.9M81.0M80.7M80.5M80.2M79.3M79.0M
Basic weighted average shares83.1M83.1M82.6M82.3M81.8M81.3M80.4M80.1M79.9M79.6M79.0M78.8M
EBITDA$275.0M$328.9M$296.0M$338.0M$295.4M$350.6M$408.8M$391.5M$354.3M$400.3M$466.6M$442.9M
EBITDA margin30.5%34.1%29.5%34.6%31.0%35.1%36.8%35.4%32.5%35.1%38.4%36.5%
Depreciation & amortization$29.74M$29.90M$32.19M$34.13M$33.71M$34.06M$35.77M$36.63M$38.72M$37.68M$41.05M$40.56M
Stock-based compensation$15.22M$14.40M$15.72M$15.92M$14.26M$14.62M$14.85M$14.43M$16.11M$16.34M$16.09M$16.22M

The main figures as JSON and plain text. See data and methodology.

IDXX in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.